Tapewire

Nasdaq · USD

QTRX

Quanterix Corp

Export transactions ↓
Tapewire entity
6649
SEC CIK
0001503274
Parsed reports
711

Last 12 months

Inside the activity.

3 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 07, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
SaleCommon Stock 8,829 $16.53 $145,908.94
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 6

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,802

F3 · price: This transaction was executed in multiple trades at prices ranging from $16.50 to $16.69. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
November 07, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionCommon Stock 8,829 $2.28 $20,130.12
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 5

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
November 07, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
SaleCommon Stock 1,171 $16.50 $19,321.50
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 4

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,802

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
November 07, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionCommon Stock 1,171 $2.28 $2,669.88
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 3

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,973

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
November 05, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.28 $0.00
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · derivative · entry 7

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,670

Underlying: Common Stock · 10,000 shares

Expires 2022-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: All shares underlying the option have vested.

Read SEC document
November 05, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
SaleCommon Stock 10,000 $17.12 $171,240.00
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 2

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,802

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.10 to $17.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
November 05, 2018 Filed Nov 7, 2018 18:18 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionCommon Stock 10,000 $2.28 $22,800.00
Disclosure

SEC source: 0001562180-18-004456 · primarydocument.xml · nonDerivative · entry 1

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
November 01, 2018 Filed Nov 5, 2018 17:30 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 2,829 $17.97 $50,842.79
Disclosure

SEC source: 0001562180-18-004421 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,170,239

F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.82 to $18.0148. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 237,500 restricted stock units.

Read SEC document
October 31, 2018 Filed Oct 31, 2018 23:44 UTC
Duffy David C.SVP R&D and CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,354 $0.00 Strike: $1.93 $0.00
Disclosure

SEC source: 0001562180-18-004345 · primarydocument.xml · derivative · entry 4

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,202

Underlying: Common Stock · 1,354 shares

Expires 2021-07-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% @ 1 year, monthly on last day of month thereafter for 3 years (starting in 12th month) beginning on 06-Jul-2011

Read SEC document
October 31, 2018 Filed Oct 31, 2018 23:44 UTC
Duffy David C.SVP R&D and CTO
Exercise / conversionStock Option (Right to Buy) · Derivative 1,860 $0.00 Strike: $2.28 $0.00
Disclosure

SEC source: 0001562180-18-004345 · primarydocument.xml · derivative · entry 3

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,253

Underlying: Common Stock · 1,860 shares

Expires 2022-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% @ 1 year, monthly on last day of month thereafter for 3 years (starting in 12th month) beginning on 01-Nov-2011

Read SEC document
October 31, 2018 Filed Oct 31, 2018 23:44 UTC
Duffy David C.SVP R&D and CTO
Exercise / conversionCommon Stock 1,860 $2.28 $4,240.80
Disclosure

SEC source: 0001562180-18-004345 · primarydocument.xml · nonDerivative · entry 2

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,485 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
October 31, 2018 Filed Oct 31, 2018 23:44 UTC
Duffy David C.SVP R&D and CTO
Exercise / conversionCommon Stock 1,354 $1.93 $2,613.22
Disclosure

SEC source: 0001562180-18-004345 · primarydocument.xml · nonDerivative · entry 1

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,952

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 5,485 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
October 02, 2018 Filed Oct 3, 2018 16:01 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 2,995 $20.91 $62,610.48
Disclosure

SEC source: 0001562180-18-004143 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,173,068

F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 6,250 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018.

F2 · price: This transaction was executed in multiple trades at prices ranging from $20.63 to $21.23. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 243,750 restricted stock units.

Read SEC document
September 05, 2018 Filed Sep 7, 2018 16:22 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
SaleCommon Stock 17,909 $14.53 $260,242.84
Disclosure

SEC source: 0001562180-18-003866 · primarydocument.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,176,063

F1 · shares: The sale of shares reported on this Form 4 was made solely to cover tax obligations upon the vesting of 50,000 RSUs and was effected pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2018.

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.10 to $15.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3 · balance_after: Includes 39,815 shares of common stock that are subject to performance based vesting and 250,000 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001104659-18-051031 · a4.xml · derivative · entry 2

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051031 · a4.xml · nonDerivative · entry 1

MEISTER PAUL M · CIK 0001033876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,270

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001104659-18-051029 · a4.xml · derivative · entry 2

Cole Douglas G. · CIK 0001486373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051029 · a4.xml · nonDerivative · entry 1

Cole Douglas G. · CIK 0001486373 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,270

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:11 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0000899243-18-021992 · doc4.xml · derivative · entry 2

Connolly John M · CIK 0001482893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:11 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0000899243-18-021992 · doc4.xml · nonDerivative · entry 1

Connolly John M · CIK 0001482893 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,270

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001104659-18-051032 · a4.xml · derivative · entry 3

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051032 · a4.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,270

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:12 UTC
WALT DAVID RDirector
GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001104659-18-051030 · a4.xml · derivative · entry 2

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:12 UTC
WALT DAVID RDirector
GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051030 · a4.xml · nonDerivative · entry 1

WALT DAVID R · CIK 0001205236 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,217,770

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 1,215,500 shares of common stock and 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:12 UTC GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001104659-18-051028 · a4.xml · derivative · entry 2

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:12 UTC GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051028 · a4.xml · nonDerivative · entry 1

DEKKERS MARIJN E · CIK 0001216068 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,648

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 117,378 shares of common stock and 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC
CRANDELL KEITHDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 7,900 $0.00 Strike: $14.80 $0.00
Disclosure

SEC source: 0001104659-18-051027 · a4.xml · derivative · entry 4

CRANDELL KEITH · CIK 0001219039 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,900

Underlying: Common Stock · 7,900 shares

Expires 2028-08-07

Read SEC document
August 07, 2018 Filed Aug 10, 2018 00:12 UTC
CRANDELL KEITHDirector · 10% owner
GrantCommon Stock 2,270 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051027 · a4.xml · nonDerivative · entry 1

CRANDELL KEITH · CIK 0001219039 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,270

F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2018. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Represents 2,270 restricted stock units.

Read SEC document
August 07, 2018 Filed Aug 9, 2018 20:12 UTC
HRUSOVSKY E KEVINDirector · Chairman, President & CEO
GrantCommon Stock 300,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-051033 · a4.xml · nonDerivative · entry 1

HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,193,972

F1 · shares: Represents restricted stock units that vest as to 50,000 shares on August 31, 2018 and as to the remainder of the shares in 40 equal monthly installments at the end of each successive month. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

F2 · balance_after: Includes 11,470 shares of common stock that are subject to time based vesting, 39,815 shares of common stock that are subject to performance based vesting and 300,000 restricted stock units.

Read SEC document
June 05, 2018 Filed Jun 5, 2018 16:15 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.28 $0.00
Disclosure

SEC source: 0001562180-18-002871 · primarydocument.xml · derivative · entry 3

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,670

Underlying: Common Stock · 25,000 shares

Expires 2022-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vests 23,335 share(s) on 02-Jan-2013, 1,944 share(s) on 31-Jan-2013, 1,944 share(s) on 28-Feb-2013, 1,944 share(s) on 31-Mar-2013, 1,944 share(s) on 30-Apr-2013, 1,944 share(s) on 31-May-2013, 1,944 share(s) on 30-Jun-2013, 1,944 share(s) on 31-Jul-2013, 1,944 share(s) on 31-Aug-2013, 1,944 share(s) on 30-Sep-2013, 1,944 share(s) on 31-Oct-2013, 1,046 share(s) on 30-Nov-2013, 1,944 share(s) on 31-Jan-2014, 1,944 share(s) on 28-Feb-2014, 1,944 share(s) on 31-Mar-2014, 1,944 share(s) on 30-Apr-2014, 1,944 share(s) on 31-May-2014, 1,944 share(s) on 30-Jun-2014, 1,944 share(s) on 31-Jul-2014, 1,944 share(s) on 31-Aug-2014, 1,944 share(s) on 30-Sep-2014, 1,944 share(s) on 31-Oct-2014, 1,944 share(s) on 30-Nov-2014, 1,944 share(s) on 31-Dec-2014, 1,944 share(s) on 31-Jan-2015, 1,944 share(s) on 28-Feb-2015, 1,944 share(s) on 31-Mar-2015, 1,944 share(s) on 30-Apr-2015, 1,944 share(s) on 31-May-2015, 1,944 share(s) on 30-Jun-2015, 1,944 share(s) on 31-Jul-2015, 1,944 share(s) on 31-Aug-2015, 1

Read SEC document
June 05, 2018 Filed Jun 5, 2018 16:15 UTC
Orticerio ErnestSVP Finance and Corporate Dev
SaleCommon Stock 25,000 $17.15 $428,632.50
Disclosure

SEC source: 0001562180-18-002871 · primarydocument.xml · nonDerivative · entry 2

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,802

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
June 05, 2018 Filed Jun 5, 2018 16:15 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionCommon Stock 25,000 $2.28 $57,000.00
Disclosure

SEC source: 0001562180-18-002871 · primarydocument.xml · nonDerivative · entry 1

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 14, 2018 21:00 UTC
Orticerio ErnestSVP Finance and Corporate Dev
GrantStock Option (right to buy) · Derivative 24,311 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001104659-18-033074 · a4.xml · derivative · entry 2

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Common Stock · 24,311 shares

Expires 2028-05-10

F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 14, 2018 21:00 UTC
Orticerio ErnestSVP Finance and Corporate Dev
GrantCommon Stock 7,131 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-033074 · a4.xml · nonDerivative · entry 1

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,802

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

F2 · balance_after: Represents 46,671 shares of common stock and 7,131 restricted stock units.

Read SEC document
May 10, 2018 Filed May 14, 2018 21:00 UTC
BAL BRUCE JVP of Ops, Service and Quality
GrantStock Option (right to buy) · Derivative 18,700 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001104659-18-033076 · a4.xml · derivative · entry 2

BAL BRUCE J · CIK 0001263377 · VP of Ops, Service and Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,700

Underlying: Common Stock · 18,700 shares

Expires 2028-05-10

F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 14, 2018 21:00 UTC
BAL BRUCE JVP of Ops, Service and Quality
GrantCommon Stock 5,485 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-033076 · a4.xml · nonDerivative · entry 1

BAL BRUCE J · CIK 0001263377 · VP of Ops, Service and Quality

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,485

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

F2 · balance_after: Represents 5,485 restricted stock units.

Read SEC document
May 10, 2018 Filed May 14, 2018 21:00 UTC
DRISCOLL JOSEPHChief Financial Officer
GrantStock Option (right to buy) · Derivative 14,960 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001104659-18-033073 · a4.xml · derivative · entry 2

DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,960

Underlying: Common Stock · 14,960 shares

Expires 2028-05-10

F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 14, 2018 21:00 UTC
DRISCOLL JOSEPHChief Financial Officer
GrantCommon Stock 4,388 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-033073 · a4.xml · nonDerivative · entry 1

DRISCOLL JOSEPH · CIK 0001392297 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,388

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

F2 · balance_after: Represents 4,388 restricted stock units.

Read SEC document
May 10, 2018 Filed May 15, 2018 01:01 UTC
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
GrantStock Option (right to buy) · Derivative 26,181 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001104659-18-033078 · a4.xml · derivative · entry 2

Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,181

Underlying: Common Stock · 26,181 shares

Expires 2028-05-10

F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 15, 2018 01:01 UTC
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
GrantCommon Stock 7,680 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-033078 · a4.xml · nonDerivative · entry 1

Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

F2 · balance_after: Represents 7,680 restricted stock units.

Read SEC document
May 10, 2018 Filed May 15, 2018 01:00 UTC
Duffy David C.SVP R&D and CTO
GrantStock Option (right to buy) · Derivative 18,700 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001104659-18-033077 · a4.xml · derivative · entry 2

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,700

Underlying: Common Stock · 18,700 shares

Expires 2028-05-10

F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 15, 2018 01:00 UTC
Duffy David C.SVP R&D and CTO
GrantCommon Stock 5,485 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-033077 · a4.xml · nonDerivative · entry 1

Duffy David C. · CIK 0001724566 · SVP R&D and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,598

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter

F2 · balance_after: Represents 31,113 shares of common stock and 5,485 restricted stock units.

Read SEC document
May 10, 2018 Filed May 15, 2018 01:00 UTC
Roskey Mark T.SVP and GM Apps and Reagents
GrantStock Option (right to buy) · Derivative 24,311 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001104659-18-033075 · a4.xml · derivative · entry 2

Roskey Mark T. · CIK 0001724565 · SVP and GM Apps and Reagents

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,311

Underlying: Common Stock · 24,311 shares

Expires 2028-05-10

F3 · derivative.exercise_date: The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
May 10, 2018 Filed May 15, 2018 01:00 UTC
Roskey Mark T.SVP and GM Apps and Reagents
GrantCommon Stock 7,131 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-033075 · a4.xml · nonDerivative · entry 1

Roskey Mark T. · CIK 0001724565 · SVP and GM Apps and Reagents

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,131

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

F2 · balance_after: Represents 7,131 restricted stock units.

Read SEC document
May 10, 2018 Filed Feb 27, 2019 21:05 UTC Amendment
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
GrantCommon Stock 7,680 $0.00 $0.00
Disclosure

SEC source: 0001562180-19-001457 · primarydocument.xml · nonDerivative · entry 1

Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,680

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on May 10, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

F2 · balance_after: Includes 17,680 shares of restricted stock units

Read SEC document
February 23, 2018 Filed Feb 27, 2018 18:03 UTC
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $22.12 $0.00
Disclosure

SEC source: 0001104659-18-012911 · a4.xml · derivative · entry 2

Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2028-02-23

F2 · derivative.exercise_date: The option vests as to 25% of the shares on February 23, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
February 23, 2018 Filed Feb 27, 2018 18:03 UTC
Mattoon DawnSr VP, Stgc Mrktg & Assay Tech
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-18-012911 · a4.xml · nonDerivative · entry 1

Mattoon Dawn · CIK 0001731785 · Sr VP, Stgc Mrktg & Assay Tech

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · shares: Represents shares of common stock issuable upon vesting of restricted stock units. The restricted stock units vest as to 25% of the shares on February 23, 2019 and vest as to an additional 2.083% of the shares per month for 36 months thereafter.

Read SEC document
December 13, 2017 Filed Dec 18, 2017 16:14 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionStock Option (right to buy) · Derivative 46,671 $0.00 Strike: $2.28 $0.00
Disclosure

SEC source: 0001104659-17-073868 · a4.xml · derivative · entry 2

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,670

Underlying: Common Stock · 46,671 shares

Expires 2022-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: All shares underlying this option have vested.

Read SEC document
December 13, 2017 Filed Dec 18, 2017 16:14 UTC
Orticerio ErnestSVP Finance and Corporate Dev
Exercise / conversionCommon Stock 46,671 $2.28 $106,409.88
Disclosure

SEC source: 0001104659-17-073868 · a4.xml · nonDerivative · entry 1

Orticerio Ernest · CIK 0001724369 · SVP Finance and Corporate Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,671

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 11, 2017 Filed Dec 11, 2017 17:27 UTC
Agarwal Ajay10% owner
ConversionSeries D Preferred Stock · Derivative 404,632 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-17-028491 · doc4.xml · derivative · entry 10

BAIN CAPITAL VENTURE INVESTORS, LLC · CIK 0001309469 · 10% owner

BAIN CAPITAL VENTURE PARTNERS 2005, L.P. · CIK 0001309470 · 10% owner

BAIN CAPITAL VENTURE FUND 2005, L.P. · CIK 0001309471 · 10% owner

BCIP Associates III, LLC · CIK 0001379475 · 10% owner

BCIP Associates III · CIK 0001379476 · 10% owner

BCIP Associates III-B, LLC · CIK 0001379517 · 10% owner

BCIP Associates III-B · CIK 0001379519 · 10% owner

KRUPKA MICHAEL A · CIK 0001212150 · 10% owner

Agarwal Ajay · CIK 0001708763 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 125,900 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares of preferred stock automatically converted into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock automatically converted on a 1-for-3.214 basis and such conversion rate is reflected in the amount of common stock underlying the security.

F1 · price: The shares of preferred stock automatically converted into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock automatically converted on a 1-for-3.214 basis and such conversion rate is reflected in the amount of common stock underlying the security.

F6 · derivative.exercise_date: These shares were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, at any time after the issuance of such shares, at the holder's election.

F7 · derivative.expiration_date: Not applicable.

F2 · ownership.nature: Bain Capital Venture Investors, LLC ("BCVI") is the general partner of Bain Capital Venture Partners 2005, L.P. ("BCVP"), which is the general partner of Bain Capital Venture Fund 2005, L.P. ("Fund 2005"). As a result, BCVP may be deemed to share voting and dispositive power with respect to the securities held by Fund 2005. BCVP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. Immediately prior to the closing of the Issuer's initial public offering on December 11, 2017, the 1,106,387 shares of the Issuer's Series A-1 Preferred Stock, 2,904,268 shares of the Issuer's Series A-2 Preferred Stock, 1,325,258 shares of the Issuer's Series B Preferred Stock, 304,948 shares of the Issuer's Series C Preferred Stock and 353,283 shares of the Issuer's Series D Preferred Stock held by Fund 2005 automatically converted into 344,239, 903,630, 412,339, 94,881 and 109,921 shares of the Issuer's common stock, respectively.

F3 · ownership.nature: Immediately prior to the closing of the Issuer's initial public offering on December 11, 2017, the 157,639 shares of the Issuer's Series A-1 Preferred Stock, 413,802 shares of the Issuer's Series A-2 Preferred Stock, 188,823 shares of the Issuer's Series B Preferred Stock, 43,449 shares of the Issuer's Series C Preferred Stock and 50,336 shares of the Issuer's Series D Preferred Stock held by BCIP Associates III, LLC ("BCIP III"), whose manager is BCIP Associates III ("BCIPA III"), whose managing partner is Boylston Coinvestors, LLC ("Boylston"), automatically converted into 49,047, 128,749, 58,750, 13,518 and 15,663 shares of the Issuer's common stock, respectively. BCIPA III may be deemed to share voting and dispositive power with respect to the securities held by BCIP III. BCIPA III disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F4 · ownership.nature: Immediately prior to the closing of the Issuer's initial public offering on December 11, 2017, the 3,174 shares of the Issuer's Series A-1 Preferred Stock, 8,331 shares of the Issuer's Series A-2 Preferred Stock, 3,799 shares of the Issuer's Series B Preferred Stock, 874 shares of the Issuer's Series C Preferred Stock and 1,013 shares of the Issuer's Series D Preferred Stock held by BCIP Associates III-B, LLC ("BCIP III-B" and together with Fund 2005 and BCIP III, the "Bain Capital Entities"), whose manager is BCIP Associates III-B ("BCIPA III-B"), whose managing partner is Boylston, automatically converted into 987, 2,592, 1,182, 271 and 316 shares of the Issuer's common stock, respectively. BCIPA III-B may be deemed to share voting and dispositive power with respect to the securities held by BCIP III-B. BCIPA III-B disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

F5 · ownership.nature: The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Entities is directed by the Executive Committee of BCVI, which consists of Michael A. Krupka and Ajay Agarwal. As a result, BCVI and Messrs. Krupka and Agarwal may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Entities. BCVI and Messrs. Krupka and Agarwal disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.